Accuray (ARAY) Income from Continuing Operations (2010 - 2026)
Accuray (ARAY) reported Income from Continuing Operations of 11805000.0 for Q1 2026, down 810.18% on a YoY basis from 1662260.88 in Q1 2025, and up 14.27% quarter-over-quarter from 13770000.0 in Q4 2025.
Accuray (ARAY) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Accuray has reported Income from Continuing Operations for 17 years, with the latest figure at 11805000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 810.18% year-over-year to 11805000.0; the trailing twelve-month figure through Mar 2026 stood at 41673000.0 (down 2050.98% YoY), and the FY2025 full-year result was 1591000.0, up 88.75% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 11805000.0, up from 13770000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 5813000.0 in Q2 2023, with the low at 21678000.0 in Q3 2025.
- Historically, Income from Continuing Operations has averaged 3284117.65 across 5 years, with a median of 1874000.0 in 2022.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations surged 157.27% — and 2024, when it tumbled 1158.76%.
- Accuray's Income from Continuing Operations stood at 1874000.0 in 2022, then slumped by 413.39% to 9621000.0 in 2023, then jumped by 126.37% to 2537000.0 in 2024, then sank by 642.77% to 13770000.0 in 2025, then gained by 14.27% to 11805000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 11805000.0 (Q1 2026), 13770000.0 (Q4 2025), and 21678000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Accuray | 41,092.55 | -38.49 Mn | 25.29 Mn | -11.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.81 Mn |
| Dec 31, 2025 | -13.77 Mn |
| Sep 30, 2025 | -21.68 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | -1.30 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | -3.95 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | -6.34 Mn |
| Dec 31, 2023 | -9.62 Mn |
| Sep 30, 2023 | -2.97 Mn |
| Jun 30, 2023 | 5.81 Mn |
| Mar 31, 2023 | 599,000.00 |
| Dec 31, 2022 | -1.87 Mn |
| Sep 30, 2022 | -5.45 Mn |
| Jun 30, 2022 | 4.60 Mn |
| Mar 31, 2022 | -1.05 Mn |
| Dec 31, 2021 | 179,000.00 |
| Sep 30, 2021 | -1.03 Mn |
| Jun 30, 2021 | 2.34 Mn |